Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood

被引：84
|
作者：
Hendricks, Robert [1 ]
Baker, Dana [1 ]
Brumm, Jochen [2 ]
Davancaze, Teresa [1 ]
Harp, Chris [3 ]
Herman, Ann [3 ]
von Budingen, H-Christian [4 ]
Townsend, Michael [5 ]
Fischer, Saloumeh K. [1 ]
机构：
[1] Genentech Inc, Dept BioAnalyt Sci, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA
[3] Genentech Inc, OMNI Biomarker Dev, San Francisco, CA 94080 USA
[4] Roche, Neurosci, Prod Dev, Basel, Switzerland
[5] Genentech Inc, Biomarker Discovery OMNI, San Francisco, CA 94080 USA
来源：
BIOANALYSIS | 2019年 / 11卷 / 15期
关键词：
Alzheimer's disease (AD); amyotrophic lateral sclerosis (ALS); biomarker; cerebrospinal fluid (CSF); multiple sclerosis (MS); neurodegeneration; neurofilament light (NfL) chain; Quanterix Simoa (TM); UmanDiagnostics Nf-Light ELISA (Uman ELISA); QUANTIFICATION; BIOMARKER; SERUM;
D O I：
10.4155/bio-2019-0163
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Background: Neurofilament light (NfL) chain is an established cerebrospinal fluid (CSF) biomarker for neuroaxonal injury. The highly sensitive Quanterix SimoaT platform is evaluated for NfLmeasurement in both CSF and blood. There is a need to link historical ELISA data that use bovine NfL to that of Simoa using a recombinant human (rhuman) NfL standard. Results/Methodology: The Simoa NF-light (R) Advantage Kit was validated for CSF and qualified for serum and plasma, using both rhuman and bovine NfL calibrators. Matched CSF, serum and plasma samples from 112 multiple sclerosis patients were analyzed using both calibrators. Conclusion: In multiple sclerosis, there is a good correlation between blood and CSF NfL levels. A conversion factor of approximately 5:1 was established between bovine and rhuman NfL calibrators.
引用
收藏
页码：1405 / 1418
页数：14
相关论文
共 50 条
  • [21] Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
    Gaetani, Lorenzo
    Salvadori, Nicola
    Lisetti, Viviana
    Eusebi, Paolo
    Mancini, Andrea
    Gentili, Lucia
    Borrelli, Angela
    Portaccio, Emilio
    Sarchielli, Paola
    Blennow, Kaj
    Zetterberg, Henrik
    Parnetti, Lucilla
    Calabresi, Paolo
    Di Filippo, Massimiliano
    JOURNAL OF NEUROLOGY, 2019, 266 (09) : 2157 - 2163
  • [22] Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis
    Lorenzo Gaetani
    Nicola Salvadori
    Viviana Lisetti
    Paolo Eusebi
    Andrea Mancini
    Lucia Gentili
    Angela Borrelli
    Emilio Portaccio
    Paola Sarchielli
    Kaj Blennow
    Henrik Zetterberg
    Lucilla Parnetti
    Paolo Calabresi
    Massimiliano Di Filippo
    Journal of Neurology, 2019, 266 : 2157 - 2163
  • [23] Cerebrospinal fluid neurofilament light chain as a potential prognostic biomarker for leptomeningeal metastasis
    Hyun, Jae-Won
    Kim, Yeseul
    Kim, Ki Hoon
    Kim, Su-Hyun
    Park, Eun Young
    Youn, Ji-Hye
    Yoo, Heon
    Gwak, Ho-Shin
    Kim, Ho Jin
    ONCOLOGY LETTERS, 2022, 24 (06)
  • [24] Cerebrospinal fluid neurofilament light chain levels in children with acquired demyelinating syndrome
    Wu, Wenlin
    Hou, Chi
    Wu, Wenxiao
    Shen, Huiling
    Zeng, Yiru
    Chen, Lianfeng
    Liao, Yinting
    Zhu, Haixia
    Tian, Yang
    Peng, Bingwei
    Chen, Wen-Xiong
    Li, Xiaojing
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [25] Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis
    Wang, Shao-Yang
    Chen, Wei
    Xu, Wei
    Li, Jie-Qiong
    Hou, Xiao-He
    Ou, Ya-Nan
    Yu, Jin-Tai
    Tan, Lan
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 72 (04) : 1353 - 1361
  • [26] Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy
    Vervuurt, Marc
    Kuiperij, H. Bea
    de Kort, Anna M.
    Kersten, Iris
    Klijn, Catharina J. M.
    Schreuder, Floris H. B. M.
    Verbeek, Marcel M.
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [27] Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
    Kuhle, Jens
    Barro, Christian
    Andreasson, Ulf
    Derfuss, Tobias
    Lindberg, Raija
    Sandelius, Asa
    Liman, Victor
    Norgren, Niklas
    Blennow, Kaj
    Zetterberg, Henrik
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2016, 54 (10) : 1655 - 1661
  • [28] Serum and cerebrospinal fluid neurofilament light chains measured by SIMOA™, Ella™, and Lumipulse™ in multiple sclerosis naïve patients.
    Vecchio, D.
    Puricelli, C.
    Malucchi, S.
    Virgilio, E.
    Martire, S.
    Perga, S.
    Passarelli, F.
    Valentino, P.
    Di Sapio, A.
    Cantello, R.
    Dianzani, U.
    Comi, C.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 82
  • [29] Comparison of the simoa and MSD R- PLEX assay to assess serum neurofilament light chain levels in hereditary transthyretin amyloidosis
    Berends, Milou
    Bijzet, Johan
    Teunissen, Charlotte E.
    in't Veld, Sjors G. J. G.
    Gans, Reinold O. B.
    Hazenberg, Bouke P. C.
    van der Zwaag, Paul A.
    Nienhuis, Hans
    Kroesen, Bart-Jan
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S92 - S93
  • [30] Neurofilament Light Chain Concentration in Cerebrospinal Fluid in Children with Acute Nontraumatic Neurological Disorders
    Geis, Tobias
    Gutzeit, Svena
    Disse, Sigrid
    Kuhle, Jens
    Fouzas, Sotiris
    Wellmann, Sven
    CHILDREN-BASEL, 2024, 11 (03):
12345